Published in Eur J Immunol on December 01, 2000
IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol (2009) 1.63
Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med (2006) 1.59
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major. J Exp Med (2004) 1.40
Modulation of dendritic cell function by Leishmania parasites. J Immunol (2008) 1.40
Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes. Infect Immun (2002) 1.31
Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J Exp Med (2003) 1.26
Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect Immun (2004) 1.22
CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. J Immunol (2010) 1.20
CD4+ T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J Exp Med (2003) 1.15
Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo. Infect Immun (2007) 1.13
Interleukin-12 p40 secretion by cutaneous CD11c+ and F4/80+ cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni. Infect Immun (2003) 1.08
Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect Immun (2002) 1.08
Hierarchy of susceptibility of dendritic cell subsets to infection by Leishmania major: inverse relationship to interleukin-12 production. Infect Immun (2002) 1.02
Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes. Infect Immun (2004) 1.02
Modulation of dendritic cell responses by parasites: a common strategy to survive. J Biomed Biotechnol (2010) 1.02
Differential interaction of dendritic cells with Rickettsia conorii: impact on host susceptibility to murine spotted fever rickettsiosis. Infect Immun (2007) 0.99
Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody. Infect Immun (2002) 0.97
CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing. Infect Immun (2004) 0.96
Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. PLoS Negl Trop Dis (2012) 0.92
Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells. Am J Pathol (2010) 0.90
Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice. Immun Ageing (2008) 0.89
UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major. J Biol Chem (2013) 0.85
Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions. Antimicrob Agents Chemother (2009) 0.83
LABCG2, a new ABC transporter implicated in phosphatidylserine exposure, is involved in the infectivity and pathogenicity of Leishmania. PLoS Negl Trop Dis (2013) 0.83
Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance. Med Microbiol Immunol (2012) 0.82
The protective Th1 response in mice is induced in the T-cell zone only three weeks after infection with Leishmania major and not during early T-cell activation. Med Microbiol Immunol (2011) 0.79
Quiescent innate response to infective filariae by human Langerhans cells suggests a strategy of immune evasion. Infect Immun (2013) 0.78
Computational analysis of cysteine proteases (Clan CA, Family Cl) of Leishmania major to find potential epitopic regions. Genomics Proteomics Bioinformatics (2009) 0.76
Influence of parasite load on the ability of type 1 T cells to control Leishmania major infection. Infect Immun (2002) 0.76
Toll-Like Receptor 2 Is Required for Inflammatory Process Development during Leishmania infantum Infection. Front Microbiol (2017) 0.75
Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells. PLoS Negl Trop Dis (2015) 0.75
Critical roles of conventional dendritic cells in promoting T cell dependent hepatitis through regulating NKT cells. Clin Exp Immunol (2016) 0.75
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41
T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci U S A (2001) 4.76
Identification of an infective stage of Leishmania promastigotes. Science (1984) 4.00
Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med (1998) 3.68
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med (2001) 3.63
Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science (2000) 2.92
Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J Immunol (1985) 2.87
In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest (1993) 2.84
Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med (1997) 2.81
Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med (2001) 2.76
A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med (1996) 2.72
Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature (1993) 2.68
An analysis of T cell responsiveness in Indian kala-azar. J Immunol (1987) 2.56
Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med (1998) 2.30
Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol (1993) 2.20
Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science (2014) 2.20
Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med (1996) 2.19
An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol (1993) 2.17
An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J Immunol (2000) 2.11
Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 2.09
Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat Med (1998) 1.99
Stage-specific adhesion of Leishmania promastigotes to the sandfly midgut. Science (1992) 1.99
Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J Immunol (1984) 1.95
Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol (1998) 1.94
Immunization of mice against African trypanosomiasis using anti-idiotypic antibodies. J Exp Med (1982) 1.86
Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis. Hum Gene Ther (1998) 1.76
Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO J (1992) 1.75
Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation. Infect Immun (1987) 1.74
CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol (1989) 1.72
The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J Immunol (2001) 1.72
Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol (2012) 1.62
Molecular characterisation of ninein, a new coiled-coil protein of the centrosome. J Cell Sci (1996) 1.59
Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc Natl Acad Sci U S A (1999) 1.59
Delayed-type hypersensitivity to Phlebotomus papatasi sand fly bite: An adaptive response induced by the fly? Proc Natl Acad Sci U S A (2000) 1.58
The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc Natl Acad Sci U S A (2000) 1.55
Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur J Immunol (1998) 1.55
Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan. Proc Natl Acad Sci U S A (1994) 1.52
Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med (1988) 1.51
Development of infective stage Leishmania promastigotes within phlebotomine sand flies. Am J Trop Med Hyg (1985) 1.50
Splenic cytokine responses in Indian kala-azar before and after treatment. J Infect Dis (1998) 1.49
Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J Immunol (1999) 1.47
Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. J Immunol (1991) 1.46
IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J Immunol (1999) 1.45
Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur J Immunol (1995) 1.45
Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells. J Immunol (2000) 1.45
Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells. Eur J Immunol (1996) 1.44
A novel role for the peritrophic matrix in protecting Leishmania from the hydrolytic activities of the sand fly midgut. Parasitology (1997) 1.43
Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur J Immunol (1999) 1.40
Membrane fractions of trypanosomes mimic the immunosuppressive and mitogenic effects of living parasites on the host. Parasite Immunol (1979) 1.40
The salivary apyrase of the blood-sucking sand fly Phlebotomus papatasi belongs to the novel Cimex family of apyrases. J Exp Biol (2001) 1.40
A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. J Clin Invest (1997) 1.35
Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol (1998) 1.33
Growth cycle-dependent generation of complement-resistant Leishmania promastigotes. J Immunol (1985) 1.30
The vectorial competence of Phlebotomus sergenti is specific for Leishmania tropica and is controlled by species-specific, lipophosphoglycan-mediated midgut attachment. Parasitology (2000) 1.27
The comparative fine structure and surface glycoconjugate expression of three life stages of Leishmania major. Exp Parasitol (1991) 1.25
Expression of a stage-specific lipophosphoglycan in Leishmania major amastigotes. Mol Biochem Parasitol (1991) 1.25
Changes in lipophosphoglycan and gene expression associated with the development of Leishmania major in Phlebotomus papatasi. Parasitology (1995) 1.22
Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting. J Clin Invest (1989) 1.21
Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63). Mol Microbiol (1998) 1.20
Characterization of a blood activated chitinolytic system in the midgut of the sand fly vectors Lutzomyia longipalpis and Phlebotomus papatasi. Insect Mol Biol (2005) 1.20
Intrinsic immunosuppressive activity of different trypanosome strains varies with parasite virulence. Nature (1980) 1.18
Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J Immunol (1990) 1.17
Late metastatic Leishmaniasis in the mouse. A model for mucocutaneous disease. Am J Trop Med Hyg (1983) 1.16
Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol (2001) 1.15
Identification of antigens recognized by T cells in human leishmaniasis: analysis of T-cell clones by immunoblotting. Infect Immun (1989) 1.14
Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells. J Immunol (1991) 1.13
Evidence that anti-idiotype induced immunity to experimental African trypanosomiasis is genetically restricted and requires recognition of combining site-related idiotopes. J Immunol (1983) 1.12
Evidence that schistosome MHC antigens are not synthesized by the parasite but are acquired from the host as intact glycoproteins. J Immunol (1983) 1.10
Retrospective review of cerebral mycotic aneurysms in 26 patients: focus on treatment in strongly immunocompromised patients with a brief literature review. AJNR Am J Neuroradiol (2012) 1.10
Human Langerhans cells express E-cadherin. J Invest Dermatol (1995) 1.09
The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. J Immunol (1996) 1.09
Deficiency in beta1,3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania-sand fly interaction. J Biol Chem (1996) 1.07
Isolation of a type-specific antigen from Chlamydia trachomatis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Immunol (1979) 1.07
Extracellular domain of pemphigus vulgaris antigen (desmoglein 3) mediates weak homophilic adhesion. J Invest Dermatol (1994) 1.07
Separation and partial characterization of a type-specific antigen from Chlamydia trachomatis. J Immunol (1978) 1.05
Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol (1996) 1.05
Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions. Biochemistry (1999) 1.02
Cell-mediated immune responses in owl monkeys (Aotus trivirgatus) with trachoma to soluble antigens of Chlamydia trachomatis. Clin Exp Immunol (1978) 1.01
Plasticity of T reg at infected sites. Mucosal Immunol (2010) 0.98
Expression of the homotypic adhesion molecule E-cadherin by immature murine thymocytes and thymic epithelial cells. J Immunol (1994) 0.98
Trypanosome-induced suppression of anti-parasite responses during experimental African trypanosomiasis. Eur J Immunol (1980) 0.98
Inhibition of host cell signal transduction by Leishmania: observations relevant to the selective impairment of IL-12 responses. Curr Opin Microbiol (1999) 0.98
T cell development in mice lacking all T cell receptor zeta family members (Zeta, eta, and FcepsilonRIgamma). J Exp Med (1998) 0.97
Thermosensitivity patterns of Old vs. New World cutaneous strains of Leishmania growing within mouse peritoneal macrophages in vitro. Am J Trop Med Hyg (1983) 0.97
E-cadherin-mediated adhesion involving Langerhans cell-like dendritic cells expanded from murine fetal skin. J Immunol (1997) 0.97
Epidermal Langerhans cells: from neurons to nature's adjuvants. Adv Dermatol (1999) 0.97
Characterization of E-cadherin-containing junctions involving skin-derived dendritic cells. J Invest Dermatol (1999) 0.96
Identification and partial characterization of a lipophosphoglycan from a pathogenic strain of Entamoeba histolytica. Mol Biochem Parasitol (1992) 0.96
Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF. Exp Parasitol (1996) 0.95
Cell surface nanoanatomy of Leishmania major as revealed by fracture-flip. A surface meshwork of 44 nm fusiform filaments identifies infective developmental stage promastigotes. Eur J Cell Biol (1989) 0.95
Comparison of the protein kinase and acid phosphatase activities of five species of Leishmania. J Protozool (1988) 0.95
Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotes. Mol Biochem Parasitol (1994) 0.95
Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: decreased intracellular glutathione inhibits an early event in the activation sequence. J Immunol (1981) 0.94
Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum. J Immunol (1991) 0.93
Induction of immune responses with anti-idiotypic antibodies: implications for the induction of protective immunity. Springer Semin Immunopathol (1983) 0.93
Regulatory role of suppressive motifs from commensal DNA. Mucosal Immunol (2012) 0.93